2. Academic Validation
  3. Nicotinamide N-oxides as CXCR2 antagonists

Nicotinamide N-oxides as CXCR2 antagonists

  • Bioorg Med Chem Lett. 2001 Jul 23;11(14):1951-4. doi: 10.1016/s0960-894x(01)00326-2.
N S Cutshall 1,  R Ursino,  K A Kucera,  J Latham,  N C Ihle
Affiliations

Affiliation

  • 1 Department of Chemistry, Celltech R&D, Inc., 1631 220th Street SE, 98021, Bothell, WA, USA. neil.cutshall@celltechgroup.com
PMID: 11459668 DOI: 10.1016/s0960-894x(01)00326-2
Abstract

A series of nicotinamide N-oxides was synthesized and shown to be novel, potent, and selective antagonists of the CXCR2 receptor. Furthermore, these compounds showed significant functional activity against GRO-alpha-driven human neutrophil chemotaxis. Compounds of this class may be useful for the treatment of inflammatory, auto-immune, and allergic disorders.

Figures
Products